The firm will share updated data and new analyses from its Phase III trial with the agency, which issued a complete response ...
Pyruvate dictates redox balance and cell size, establishing metabolism as a dominant regulator of cellular fitness, unveiling new strategies to modulate cancer, regeneration, and diabetes.
FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an additional clinical trial ROSWELL, ...
Saol Therapeutics received a complete response letter for its pyruvate dehydrogenase complex deficiency treatment a week ...
Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis being the primary contributor to poor patient outcomes. A critical factor in ...
Opinion
9dOpinion
Hope for PDCD Foundation Delivers Petition to FDA Urging Approval of the First Targeted PDCD Treatment
Petition Rapidly Garnered More than 17,000 Signatures in Under 2 MonthsFOLSOM, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Hope for PDCD Foundation, a parent-led patient advocacy group dedicated to ...
Indications: Pyruvate dehydrogenase complex deficiency, typically associated with post-prandial lactic acidemia with a normal lactate/pyruvate ratio, can be assayed in freshly isolated blood ...
The pyruvate dehydrogenase complex consists of many different enzymes (marked in different colours). Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to ...
Malaria that is caused by Plasmodium falciparum is a significant global health problem. Genetic characteristics of the host influence the severity of disease and the ultimate outcome of infection, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results